Stop the Albuterol and Investigate the Underlying Cause
If a patient is using albuterol 2-3 times daily for cough alone, you should discontinue the albuterol and pursue diagnostic evaluation to identify the actual cause of the cough. Albuterol is not indicated for cough that is not due to asthma, and continuing it exposes the patient to unnecessary side effects without benefit 1.
Why Albuterol Should Be Stopped
The ACCP evidence-based guidelines explicitly state that in patients with acute or chronic cough not due to asthma, albuterol is not recommended (Grade D recommendation) 1. This is supported by multiple randomized controlled trials:
- In non-asthmatic children with acute cough, oral albuterol showed no reduction in cough frequency or duration, but caused significantly more trembling and shaking 2
- In ambulatory adults with acute nonspecific cough, albuterol provided no benefit in cough severity, sleep quality, or return to activity, while causing more shakiness and nervousness 3
The FDA label for albuterol clearly indicates it is for bronchospasm treatment, not cough suppression 4. Using it 2-3 times daily for cough alone suggests misuse of the medication.
Potential Harm from Continued Use
Regular albuterol use (even at therapeutic doses) can worsen underlying conditions:
- Regular use increases allergen-induced late asthmatic responses and airway inflammation 5
- It can worsen baseline airway caliber and increase airway responsiveness 6
- Side effects include tremor, nervousness, tachycardia, and potential paradoxical bronchospasm 4
What to Do Instead
Identify the actual cause of the cough through targeted evaluation:
1. Assess for Asthma or Its Variants
- If the patient has documented asthma with cough as a symptom, albuterol may be appropriate, but using it 2-3 times daily suggests inadequate control
- Cough variant asthma should be managed following national asthma guidelines, with inhaled corticosteroids as the cornerstone therapy 7
- At step 3, use leukotriene receptor antagonists rather than long-acting beta-agonists for cough variant asthma 7
- Eosinophilic bronchitis and atopic cough respond to inhaled corticosteroids, not bronchodilators alone 7
2. Evaluate for Upper Airway Disease
- Look for nasal stuffiness, sinusitis, or post-nasal drip symptoms 7
- Trial of topical nasal corticosteroids for 1 month if upper airway symptoms are prominent 7
- Note that symptoms and clinical findings are not reliable discriminators; response to treatment is diagnostic 7
3. Consider Gastroesophageal Reflux Disease (GORD)
- GORD accounts for 5-41% of chronic cough cases 7
- Trial of proton pump inhibitors (omeprazole 20-40 mg twice daily before meals) for at least 8 weeks 7
- May add prokinetic agents like metoclopramide 10 mg three times daily 7
Common Pitfalls to Avoid
- Don't continue albuterol just because the patient has been using it - this perpetuates inappropriate therapy
- Don't assume cough equals asthma - most chronic cough in adults is not due to asthma
- Don't use albuterol as a cough suppressant - it has no antitussive properties in non-asthmatic cough
- Recognize that frequent albuterol use (>2 times/week) in true asthmatics indicates poor control and requires step-up in controller therapy, not more rescue medication